Recombinant human parathyroid hormone

Recombinant human parathyroid hormone, marketed under the trade name Natpara, is an artificially manufactured form of the parathyroid hormone used to treat hypoparathyroidism.[1][2]

References

  1. ↑ "FDA approves Natpara to control low blood calcium levels in patients with hypoparathyroidism". http://www.fda.gov/. Retrieved 30 January 2015. External link in |website= (help)
  2. ↑ "Natpara Approval History". drugs.com. Retrieved 30 January 2015.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.